Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

8,582 total articles

Sea Limited: Brazil Momentum and Shopee Edge Set Up a Tactical Long

Sea Limited: Brazil Momentum and Shopee Edge Set Up a Tactical Long

Sea (SE) is trading well below its 52-week high after a late-cycle sell-off but recent results and aggressive share gains in Brazil create a concrete catalyst for a multi-week rebound. We outline an actionable long with entry at $84.78, stop at $76.00 and a $140 target over a 45- to 180-trading-day horizon, backed by strong revenue acceleration, im…

Nano Labs: The Quiet AI Bottleneck Play With Microcap Upside

Nano Labs: The Quiet AI Bottleneck Play With Microcap Upside

Nano Labs (NA) is a small Hangzhou-based fabless chip designer whose product set - high-throughput compute chips, smart network interface cards, distributed compute/storage and vision chips - sits squarely at a little-discussed bottleneck for AI deployments: moving data to and through accelerators. The stock trades at $1.77 with a market cap of rou…

Buying Coeur Mining After New Gold Deal: Net-Cash Balance Sheet, Big Buyback, and North American Scale

Buying Coeur Mining After New Gold Deal: Net-Cash Balance Sheet, Big Buyback, and North American Scale

Coeur Mining's expanded North American footprint, strong liquidity (low leverage, healthy current ratio), ~$915M in trailing free cash flow and a $750M buyback make the stock a compelling long for patient, cash-flow-focused investors. This trade plan lays out an entry, stop and target for a long-term position that banks on buybacks, production scal…

Organogenesis: Market Fixated on ReNu—Wound-Care Cash Flow and a Quiet PuraPly Win Make a Compelling Long

Organogenesis: Market Fixated on ReNu—Wound-Care Cash Flow and a Quiet PuraPly Win Make a Compelling Long

Organogenesis (ORGO) trades at roughly $303M market cap while the market obsesses over ReNu's setbacks. A positive randomized trial for PuraPly AM and steady wound-care cash flow, coupled with elevated short interest and attractive valuation multiples (EV/sales ~0.48; EV/EBITDA ~7.96), create a mid-term trade with defined risk. Entry $2.36, stop $1…

Apollo: Fee-Generating AUM Momentum Supports a Tactical Long into 2026

Apollo: Fee-Generating AUM Momentum Supports a Tactical Long into 2026

Apollo Global Management has been actively building fee-generating assets through acquisitions and private-credit deployments. The business mix and balance-sheet profile support continued margin capture as markets reprice alternatives. This trade targets capital appreciation toward the prior 52-week high, using tight risk controls and a 180-trading…

SPS Commerce: Durable Cloud Franchise, Reasonable Valuation, and a Clear Path to Re-accelerating Growth

SPS Commerce: Durable Cloud Franchise, Reasonable Valuation, and a Clear Path to Re-accelerating Growth

SPS Commerce (SPSC) is a mature cloud provider for retail supply chains with steady cash generation, modest leverage, and a valuation that looks reasonable given its profitability profile. Recent tuck-in acquisitions and AI investments, combined with a trough in sentiment and a P/S near decade lows, set the stage for above-market returns if executi…

Apollo Global: Buy the Dip — Temporary Fee Realizations Cloud Near-Term EPS, But Core Earnings Path Intact

Apollo Global: Buy the Dip — Temporary Fee Realizations Cloud Near-Term EPS, But Core Earnings Path Intact

Apollo Global Management (APO) faces near-term headwinds from uneven realized performance fees and an EPS trough, but balance-sheet strength, fee-bearing AUM growth and strategic acquisitions make a compelling long opportunity. Enter on modest weakness, limit downside with a defined stop, and hold into H2 2026 catalysts where deal closings and fee …

Oracle After the Sell-Off: Tactical Long on Durable Cloud Cash Flow

Oracle After the Sell-Off: Tactical Long on Durable Cloud Cash Flow

Oracle's June sell-off over a $40B financing plan and aggressive AI infrastructure spending creates a tactical buying opportunity. Fundamentals remain intact: record quarterly results, $638B of remaining performance obligations and a $529B market cap. Negative free cash flow and elevated debt are real, but the risk/reward favors a measured long wit…

Lumentum: A Volatile Way to Own the Silicon-Photonic Backbone of AI

Lumentum: A Volatile Way to Own the Silicon-Photonic Backbone of AI

Lumentum (LITE) sits at the center of an AI infrastructure squeeze: hyperscalers need optical interconnects and silicon photonics, and Lumentum has the IP and capacity roadmap. The stock is richly priced today - market cap ~$71.7B and EV/sales ~29x - but demand signals, Nvidia strategic investment chatter, and a visible factory build could push sha…